Adam Wernick, PRI, November 19, 2018
Pharmaceutical and chemical giant Bayer has shed some $20 billion in market value in the weeks since a California court ordered it to pay $289 million in damages to plaintiff Dewayne Lee Johnson, related to his use of the herbicide Roundup.
Jurors found that Monsanto, now owned by Bayer in a $66 billion merger, had acted with malice and negligence in failing to warn Johnson, a former school groundskeeper, about the cancer risks associated with Roundup and its key ingredient, glyphosate. Johnson is now suffering from late-stage non-Hodgkins lymphoma.
The German-based company Bayer merged with Monsanto in June 2018, just two months before the California jury ruled unanimously in favor of Mr. Johnson. Now, Bayer is on the hook for the $289 million in damages.
Carey Gillam, a journalist who has reported extensively on Monsanto, places the blame for Bayer’s predicament on executives who failed to properly warn their shareholders that this potential liability existed.
Latest USRTK In the News
With Monsanto and Glyphosate on the Run AAAS Revokes Award to Scientists Whose Studies Led to Ban on Weedkiller in Sri Lanka and Other Countries
Editor, Corporate Crime Reporter, February 18, 2019
Ingredient in Popular Weed Killer Raises Cancer Risk, Study Finds
Nancy Clanton, Atlanta Journal-Constitution, February 15, 2019
Ever Wonder How Coca-Cola Influences Health Policy? Here Are the Documents
Dan Nosowitz, Modern Farmer, February 13, 2019
Coca-Cola and Obesity: Study Shows Efforts to Influence US Centers for Disease Control
Gareth Iacobucci, BMJ, January 30, 2019
Coca-Cola Tried to Influence CDC on Research and Policy, New Report States
Jesse Chase-Lubitz, Politico, January 29, 2019